Apposite Capital, a private equity firm, completed an investment in Emblation, a medical devices company. Financial terms were not disclosed. “We are pleased to have secured an investment from Apposite Capital which will allow us to accelerate our international expansion into new and existing markets as well as continue to build on our technology platform and deliver ground-breaking clinical results. Apposite immediately recognised the growth potential of our technology, and I am particularly excited to be working with the firm given their understanding of the sector and their expertise in scaling-up businesses like ours," Gary Beale, Emblation CEO.